Expanded Access and Right to Try: Latest Legislative and Regulatory Developments

A CenterWatch Webinar

Expanded Access and Right to Try: Latest Legislative and Regulatory Developments

APRIL
16

Tuesday, April 16, 2019 · 1:30-3:00 pm EDT
Location: Your office or conference room (no need to travel!)

Are you, like many of your colleagues, eager to learn more about Right to Try?

You might be interested to know that the law clarifies adverse events and it’s liability protections have spurred an increased appeal in this pathway.

How can you integrate Right to Try with your compassionate use program while still supporting clinical research? What are best practices for forging ahead on these programs without slighting ongoing new drug development?

Naomi Lopez Bauman will discuss:

  • Company factors to consider for incorporating Right to Try
  • Types of companies that are (or about to begin) practicing Right to Try
  • Companies’ ability to use the law’s cost recovery provisions to recoup direct costs
  • Companies compliance with the law’s reporting requirements, in the absence of specific guidance or rules from the administration
  • Current and future implications for the clinical trial process
  • Patient engagement’s impact on this movement, and upcoming possible changes

Start integrating Right to Try into your global compassionate use programs. .

Who Will Benefit

  • Executive suite
  • New product strategists
  • Clinical trials/clinical development
  • CRO/strategic planning/business development
  • CMO/medical affairs
  • Regulatory/compliance
  • Project management
  • Risk management
  • Quality control/GMP/cGMP
  • GC/legal affairs/outside counsel
  • Physicians
  • Consultants

Meet Your Presenter:

Naomi Lopez BaumanNaomi Lopez Bauman is the director of healthcare policy at the Goldwater Institute. She has more than 25 years of public policy experience at both the federal and state levels. Bauman has testified before Congress & state legislatures across the country. Her current research interests include off-label communications, pharmaceutical pricing & transparency, Right to Try, state insurance markets, scope of practice reforms, 1115 &1332 waivers, and healthcare disruption.

 

REGISTER NOW
Webinar plus USB Audio Recording/Transcript

Best Value! You’ll have access to one log-in for the live 90-minute webinar for unlimited participants. You also receive all presentation materials and the opportunity to ask questions by phone and email, plus an audio recording and transcript for the entire session. Delivery is approximately two weeks after the session.

Price: $487.00
Webinar Only

You get one log-in for the live 90-minute webinar for unlimited participants, presentation materials and the opportunity to ask questions by phone and email.

Price: $287.00
24/7 Encore plus USB Audio Recording/Transcript

You'll have access to one log-in for an archived recording of the entire 90-minute webinar, including the Q&A period, for unlimited participants. You can log in any time of day or night. You'll also receive all presentation materials, plus an audio recording and transcript for the entire session. Delivery is approximately two weeks after the session.

Price: $487.00
24/7 Encore Presentation

You'll have access to one log-in for an archived recording of the entire 90-minute webinar, including the Q&A period, for unlimited participants. You can log in any time of day or night. You'll also receive all presentation materials.

Price: $287.00
USB Audio Recording/Transcript

You'll receive an audio recording and written transcript of the entire 90-minute webinar, including the Q&A period, and all presentation materials. Delivery is approximately two weeks after the session.

Price: $287.00

Invite your entire team for maximum benefit!
Register TODAY for one dial-in and log-in and bring as many participants as you wish.

Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally to learn about our special multisite discount.